Brief: Virios Therapeutics Announces Research Collaboration For Treating Long Covid
28/02/2022 12:14
Feb 28 (Reuters) - Virios Therapeutics Inc VIRI.O :
* VIRIOS THERAPEUTICS ANNOUNCES RESEARCH COLLABORATION
EXPLORING
THE POTENTIAL OF COMBINATION ANTIVIRAL THERAPY FOR TREATING LONG
COVID
* VIRIOS - COLLABORATION WITH BATEMAN HORNE CENTER ("BHC")
OF SALT
LAKE CITY, UTAH, TO EXPLORE ROLE OF COMBINATION ANTIVIRAL
THERAPY IN LONG COVID
Source text for Eikon: ID:nBw6hrBf2a
Further company coverage: VIRI.O
((reuters.briefs@thomsonreuters.com;))
Recent news on Dogwood Therapeutics
See all newsDogwood Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Dogwood Therapeutics Q2 net loss widens on higher costs, impairment charge
Brief: Dogwood Therapeutics Q2 EPS USD -0.34
Dogwood Therapeutics Inc expected to post a loss of 14 cents a share - Earnings Preview
Brief: Dogwood Therapeutics Announces Commencement Of Halneuron® Chemotherapy Induced Neuropathic Pain Phase 2B Long Term Extension Study